Urdu Version of the Dynamic Gait Index: Reliability and Validity Study
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Apr 27, 2021
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
The aim of study is to translate and culturally adapt DGI into Urdu language and secondly to investigate the reliability and validity of DGI in geriatrics Pakistani population.This study will be cross sectional survey in which convenience sampling technique will be used to enroll participants as per pre-defined criteria.
The results of study will help to know the validity and reliability of DGI in Urdu version with balance impairments in geriatric population.The reliability of the scale will be checked through internal consistency and test-retest methods. Internal consistency will be analy...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age at least 65 years
- • Ability to walk a minimum of 6m with or without a walking Aid
- • One or more falls in the last year or
- • Observed balance impairment evaluated subjectively by a physical therapist during the initial training session (Time Up and Go test, Morse Fall Scale)
- Exclusion Criteria:
- • Inability to understand or follow the instructions of the DGI
- • Experience with the DGI in the last 6 months
- • Acute illness or fracture in the lower extremities or knee/hip replacement within the last 3 months.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Faisalabad, Punjab, Pakistan, Pakistan
Faisalabad, Punjab, Pakistan
Patients applied
Trial Officials
Muhammad Kashif
Study Chair
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials